Socio-economic status and 1 year mortality among patients hospitalized for heart failure in China

Yilan Ge1, Lihua Zhang1, Yan Gao1

  • 1National Clinical Research Center for Cardiovascular Diseases, NHC Key Laboratory of Clinical Research for Cardiovascular Medications, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Center for Cardiovascular Diseases, Beijing, People's Republic of China.

ESC Heart Failure
|January 7, 2022
PubMed

Insights

Socio-economic status (SES) significantly impacts heart failure (HF) patient mortality in China. Lower income, education, employment, and partner status increase death risk, highlighting the need for targeted interventions for vulnerable HF patients.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Heart failure (HF) is a major cause of hospitalization and mortality worldwide.
  • Socio-economic status (SES) is increasingly recognized as a determinant of health outcomes.
  • The prognostic impact of SES on HF mortality in China remains underexplored.

Purpose of the Study:

  • To investigate the association between SES and 1-year all-cause mortality in hospitalized HF patients in China.
  • To determine if SES provides incremental prognostic value beyond traditional risk factors for HF mortality.
  • To inform the development of targeted interventions for socio-economically disadvantaged HF patients.

Main Methods:

  • Analysis of data from the China Patient-centred Evaluative Assessment of Cardiac Events-Prospective Heart Failure Study (China PEACE 5p-HF Study) (2016-2018).
  • SES assessed via income, employment, education, and partner status, with individual socio-economic risk factor (SERF) scores.
  • Cox proportional hazards models and Harrell c-statistic used to evaluate mortality risk and prognostic improvement.

Main Results:

  • Low/middle income, unemployment, low education, and unpartnered status were independently associated with increased 1-year all-cause mortality.
  • Patients with more SERFs exhibited substantially higher mortality risk (e.g., 4 SERFs: 3.20-fold increased risk).
  • Inclusion of SES in a clinical model significantly improved mortality prediction (c-statistic increment of 0.01, P < 0.01).

Conclusions:

  • SES is a critical predictor of mortality in Chinese patients hospitalized for HF.
  • Addressing socio-economic disparities is essential for improving outcomes in HF management.
  • Clinical interventions should be tailored to mitigate the excess mortality risk in socio-economically deprived HF populations.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
69
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
114
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
335
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
50
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
168